Global Action Plan on HIV Drug Resistance 2017–2021: 2018 progress report

Overview

The rise in antimicrobial resistance is a growing global health concern that requires collective and coordinated action. Minimizing the emergence and transmission of drug-resistant HIV is a critical aspect of the global response to antimicrobial resistance. Increasing prevalence of HIV drug resistance to commonly used antiretroviral drugs poses a threat to the HIV response, with the potential to fuel an increase in HIV incidence, mortality and treatment costs if not adequately addressed.

This report summarizes the progress in implementing the Global Action Plan achieved during the first year (2017 to 2018) and the remaining challenges, with specific focus on 45 countries accounting for more than 85% of the total burden of HIV infection.